Pharma News

EMA’s safety committee (PRAC) recommended that patients stop using Picato (ingenol mebutate), a gel for treating the skin condition actinic keratosis, while it continues its review of the medicine’s safety.

Declining private investment and lack of innovation in the development of new antibiotics are undermining efforts to combat drug-resistant infections, says the World Health Organization (WHO).

A French-Swiss consortium is conducting exploratory research to develop a“smart  bra”  for  detecting  breast  cancer.  It  wants  to  leverage  technological  progress  to  offer  a  more  accessible  diagnostic  method  than  mammography.  This  initiative  –  that  involves  five  partners  –  is supported in France by the FEDER (European fund for regional development) and in Switzerland by the Confederation  and  the  canton  of  Neuchâtel  within  the  framework  of  the  European  program  for  regional cooperation Interreg France-Switzerland.

Strides Pharma Science Limited (Strides)  announced that its step down subsidiary, Strides Pharma Inc. (SPI), has received an Establishment Inspection Report (EIR) from the USFDA for its facility in Riviera Beach, Florida, US. The EIR was issued as an outcome of the USFDA’s inspection of the facility in December 2019. This facility is one of the very few manufacturing facilities in the US with a soft gel capsule(SGC) manufacturing suite for formulations with containment needs.

Researchers of the ICAI Group –Computational Intelligence and Image Analysis– of the University of Malaga (UMA) have designed an unprecedented method that is capable of improving brain images obtained through magnetic resonance imaging using artificial intelligence.

Director CCMB, Dr Rakesh K Mishra (Third from left) with researchers

Researcher from India and USA, who work to understand the genetic basis of diseases among various ethnic populations from different parts of the world, participated in a workshop organized by CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad. The workshop focussed on understanding genome information in a better way. Improved information on genome can help fine-tune genome-assisted healthcare, and could even lead to precise, personalized, more effective and economical approaches to healthcare.

In a significant development, WHO Global Tuberculosis Programme has included an Indian molecular assay as initial test for detecting the disease and for identifying resistant strains of the TB bacteria.

In a new study that could lead to deeper insights into the mechanism behind a wide range of nervous system disorders and diseases, researchers at the Department of Biotechnology’s Pune-based National Centre for Cell Science (NCCS) have captured three-dimensional views of a protein called GluD1 receptor.

Clarivate Analytics plc a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced it has signed a definitive agreement to acquire Decision Resources Group (“DRG”), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group. The $950 million purchase price–approximately 12x trailing DRG Adjusted EBITDA, taking into account acquisition cost synergies but not revenue synergies–includes $900 million in cash and approximately $50 million in Clarivate ordinary shares to be issued following the one-year anniversary of closing. The acquisition is expected to be accretive to Clarivate earnings in 2020.